Quince Therapeutics Inc (QNCX) produces promising results

Within its last year performance, QNCX rose by 91.55%, with highs and lows ranging from $2.45 to $0.51, whereas the simple moving average jumped by 3.07% in the last 200 days.

On March 24, 2025, Oppenheimer started tracking Quince Therapeutics Inc (NASDAQ: QNCX) recommending Outperform.

Analysis of Quince Therapeutics Inc (QNCX)

Quince Therapeutics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -130.90% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.05, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and QNCX has an average volume of 315.79K. On a monthly basis, the volatility of the stock is set at 5.36%, whereas on a weekly basis, it is put at 9.71%, with a gain of 8.80% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.25, showing growth from the present price of $1.36, which can serve as yet another indication of whether QNCX is worth investing in or should be passed over.

How Do You Analyze Quince Therapeutics Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 23.01%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 11.09% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

QNCX shares are owned by institutional investors to the tune of 11.09% at present.

Hot this week

GoodRx Holdings Inc (GDRX)’s results reveal risk

While GoodRx Holdings Inc has overperformed by 1.92%, investors...

Was there any good news for Similarweb Ltd (SMWB) stock in the last session?

While Similarweb Ltd has underperformed by -0.23%, investors are...

It would be worthwhile to take a closer look at Coherus Oncology Inc (CHRS)

While Coherus Oncology Inc has overperformed by 4.58%, investors...

How should investors view Nexxen International Ltd (NEXN)?

While Nexxen International Ltd has underperformed by -2.57%, investors...

Cimpress plc (CMPR) is an excellent investment, but the stock is overvalued/undervalued right now

While Cimpress plc has overperformed by 2.21%, investors are...

Topics

GoodRx Holdings Inc (GDRX)’s results reveal risk

While GoodRx Holdings Inc has overperformed by 1.92%, investors...

Was there any good news for Similarweb Ltd (SMWB) stock in the last session?

While Similarweb Ltd has underperformed by -0.23%, investors are...

It would be worthwhile to take a closer look at Coherus Oncology Inc (CHRS)

While Coherus Oncology Inc has overperformed by 4.58%, investors...

How should investors view Nexxen International Ltd (NEXN)?

While Nexxen International Ltd has underperformed by -2.57%, investors...

Have you been able to find a good deal on Nu Skin Enterprises, Inc’s shares?

While Nu Skin Enterprises, Inc has underperformed by -0.45%,...

A closer look at Concentrix Corp (CNXC) is warranted

While Concentrix Corp has overperformed by 0.98%, investors are...

CERT (Certara Inc) has impressive results

While Certara Inc has underperformed by -0.26%, investors are...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.